Page 334 - fbkCardioDiabetes_2017

310 Diabetic Cardiomyopathy :
Mechanisms, Diagnosis and Treatment

12. Voulgari C, Papadogiannis D, Tentolouris N. Diabetic cardiomyopathy: (SOLVD) Trials and Registry. Am J Cardiol. 1996; 77: 1017-1020.
from the pathophysiology of the cardiac myocytes to current diagnosis
and management strategies. Vasc Health Risk Manag. 2010; 6: 883-903. 31. Shorr RI, Ray WA, Daugherty JR, Griffin MR. Antihypertensives and the
risk of serious hypoglycemia in older persons using insulin or sulfonylureas.
13. Ernande L, Rietzschel ER, Bergerot C, et al. Impaired myocardial radial JAMA. 1997; 278: 40-43.
function in asymptomatic patients with type 2 diabetes mellitus: a speck-
le-tracking imaging study. J Am SocEchocardiogr. 2010; 23: 1266-1272. 32. Fernandez HM, Leipzig RM. Spironolactone in patients with heart failure.
N Engl J Med. 2000; 342: 132.
14. Zabalgoitia M, Ismaeil MF, Anderson L, Maklady FA. Prevalence of diastolic
dysfunction in normotensive, asymptomatic patients with well-controlled 33. Swedberg K, Komajda M, Böhm M, et al. Ivabradine and outcomes in
type 2 diabetes mellitus. Am J Cardiol. 2001; 87: 320-323. chronic heart failure (SHIFT): a randomised placebo-controlled study.
Lancet. 2010; 376: 875-885.
15. Kosmala W, Przewlocka-Kosmala M, Mazurek W. Subclinical right ven-
tricular dysfunction in diabetes mellitus—an ultrasonic strain/strain rate 34. Du, X., Matsumura, T., Edelstein, D. et al. (2003) Inhibition of GAPDH
study. Diabet Med. 2007; 24: 656663. activity by poly (ADP-ribose) polymerase activates three major pathways of
hyperglycemic damage in endothelial cells. J. Clin. Invest. 112, 1049–1057
16. Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: evidence, mech-
anisms, and therapeutic implications. Endocr Rev. 2004; 25: 543-567. 35. Szabo, C., Zanchi, A., Komjati, K. et al. (2002) Poly(ADP-ribose) poly-
merase is activated in subjects at risk of developing type 2 diabetes and is
17. Ng AC, Delgado V, Bertini M, et al. Findings from left ventricular strain associated with impaired vascular reactivity. Circulation 106, 2680–2686
and strain rate imaging in asymptomatic patients with type 2 diabetes
mellitus. Am J Cardiol. 2009; 104: 1398-1401.
18. Galderisi, M., Anderson, K. M., Wilson, P. W. and Levy, D. (1991) Echocar-
diographic evidence for the existence of a distinct diabetic cardiomyopathy
(TheFraminghamHeartStudy).Am.J.Cardiol.68,85–89
19. Kimball, T. R., Daniels, S. R., Khoury, P. R., Magnotti, R. A., Turner, A.
M. and Dolan, L. M. (1994) Cardiovascular status in young patients with
insulin dependent diabetes mellitus. Circulation 90, 357–361
20. Eren, M., Gorgulu, S., Uslu, N., Celik, S., Dagdeviren, B. and Tezel, T.
(2004) Relationship between aotric stiffness and left ventricular diastolic
dysfunction in patients with hypertension, diabetes, or both. Heart 90,
37–43
21. Vinereanu, D., Nicolaides, E., Tweddel, A. C. et al. (2003) Subclinical
left ventricular dysfunction in asymptomatic patients with Type II diabe-
tes mellitus, related to serum lipids and glycatedhaemoglobin. Clin. Sci.
105, 591–599
22. Perez, J. E., McGill, J. B., Santiago, J. V. et al. (1992) Abnormal myocardial
acoustic properties in diabetic patients and their correlation with the
severity of disease. J. Am. Coll. Cardiol. 19, 1154–1162
23. Cohen, J. L., Cherif, J., Segar, D. S. et al. (1998) Improved left ventricular
endocardial border delineation and opacification with OPTISON (FS069), a
new echocardiographic contrast agent. Results of a phase III Multicenter
Trial. J. Am. Coll. Cardiol. 32, 746–752
24. Sogaard, P., Egeblad, H., Pedersen, A. K. et al. (2002) Sequential versus
simultaneous biventricular resynchronization for severe heart failure: eval-
uation by tissue Doppler imaging. Circulation 106, 2078–2084
25. Wolfe, M. L., Iqbal, N., Gefter, W., Mohler, III, E. R., Rader, D. J. and Reilly,
M. P. (2002) Coronary artery calcification at electron beam computed
tomography is increased in asymptomatic type 2 diabetics independent
of traditional risk factors. J. Cardiovasc. Risk 9, 369–376
26. Ficaro, E. P. and Corbett, J. R. (2004) Advances in quantitative perfusion
SPECT imaging. J. Nucl. Cardiol. 11, 62–70
27. Kodama S, Tanaka S, Heianza Y, et al. Association between physical ac-
tivity and risk of all-cause mortality and cardiovascular disease in patients
with diabetes: a meta-analysis. Diabetes Care. 2013; 36: 471-479.
28. Tahrani AA, Varughese GI, Scarpello JH, Hanna FW. Metformin, heart
failure, and lactic acidosis: is metformin absolutely contraindicated? BMJ.
2007; 335: 508-512.
29. Bloomgarden ZT. Glycemic control in diabetes: a tale of three studies.
Diabetes Care. 2008; 31: 1913-1919.
30. Shindler DM, Kostis JB, Yusuf S, et al. Diabetes mellitus, a predictor of
morbidity and mortality in the Studies of Left Ventricular Dysfunction

GCDC 2017